AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Alnylam Pharmaceuticals, Inc.

€207.2 -$132.50 (-39.01%)
XETRA · 16 Sep 2026 07:04 UTC
Previous Close
€210.4
Day Range
€207.2 - €207.2
Year Range
€177.1€407.5
Market Cap
27.73B
AVG Volume
140
Trailing/Forward PE
39.06/20.88
PEG ratio
0.77
Dividend Yield
-
Next Earnings Date
2026-10-29
Primary Exchange
Deutsche BörseDE
Revenue (USD) · TTM
02B4B6B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUL.DE Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q24.8B
26 Q14.28B
25 Q43.71B
25 Q33.2B
25 Q22.46B
25 Q12.35B
24 Q42.25B
24 Q32.09B
24 Q22.34B
24 Q12B
Net Income (USD) · TTM
-500M0500M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUL.DE Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2807.68M
26 Q1577.13M
25 Q4313.63M
25 Q343.43M
25 Q2-318.75M
25 Q1-269.73M
24 Q4-278.16M
24 Q3-332.26M
24 Q2-72.94M
24 Q1-332.08M
Operating Income (USD) · TTM
-500M0500M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUL.DE Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2999.3M
26 Q1751.55M
25 Q4501M
25 Q3264.11M
25 Q2-180.09M
25 Q1-115.36M
24 Q4-176.88M
24 Q3-188.13M
24 Q2102.64M
24 Q1-175.8M
EBITDA (USD) · TTM
-500M0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUL.DE EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q21.15B
26 Q1923.84M
25 Q4630.8M
25 Q3154.97M
25 Q2-234.1M
25 Q1-244.92M
24 Q4-271.19M
24 Q3-192.22M
24 Q2105.39M
24 Q1-123.25M
Cash Flows (USD) · TTM
-250M0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUL.DE Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2794.21M
26 Q1641.35M
25 Q4465.39M
25 Q3221.36M
25 Q2-52.09M
25 Q1-75.39M
24 Q4-42.59M
24 Q316.06M
24 Q2318.87M
24 Q1127.82M
EPS (USD) · TTM
-5-2.502.557.524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUL.DE EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q25.92
26 Q14.21
25 Q42.26
25 Q30.25
25 Q2-2.46
25 Q1-2.09
24 Q4-2.17
24 Q3-2.62
24 Q2-0.6
24 Q1-2.77
Expenses (USD) · TTM
01B2B3BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUL.DE Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q22.92B
26 Q12.78B
25 Q42.58B
25 Q32.47B
25 Q22.27B
25 Q12.17B
24 Q42.14B
24 Q32.02B
24 Q21.99B
24 Q11.92B
Shares Outstanding (USD) · TTM
-400M-300M-200M-100M0Buybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUL.DE Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-250M
26 Q1-361.68M
25 Q4-348.24M
25 Q3-368.25M
25 Q2-305.84M
25 Q1-283.45M
24 Q4-272.08M
24 Q3-222.43M
24 Q2-240.57M
24 Q1-227.08M
PE Ratio
050010001500med 126.95Jan 26Feb 26Apr 26May 26Jun 26Aug 26Sep 26
DUL.DE PE Ratio by quarter
PeriodPE Ratio
Sep 2655.08
Sep 2657.36
Sep 2661.22
Aug 2654.51
Aug 2654.32
Aug 2652.52
Aug 2650.41
Jul 2647.25
Jul 2662.52
Jul 2661.76
Jul 2668.88
Jul 2672.85
Jun 26122.93
Jun 26116.58
Jun 26119.24
Jun 26127.32
May 26126.59
May 26125.34
May 26121.22
May 26124.68
Apr 26130.07
Apr 26128.63
Apr 26130.34
Apr 26135.99
Apr 26134.5
Mar 26956.66
Mar 26946.69
Mar 26951.27
Mar 26972.46
Feb 261008.38
Feb 261020.69
Feb 26948.56
Feb 26993.9
Jan 261025.9
Jan 261088.17
Jan 261083.94
Jan 261204.64
Jan 261205.24
Free Cash Flow Yield
-1%0%1%2%3%med 0.05%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
DUL.DE Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 262.02%
Sep 261.94%
Sep 261.82%
Aug 262.04%
Aug 262.05%
Aug 262.12%
Aug 262.2%
Jul 262.35%
Jul 261.78%
Jul 261.8%
Jul 261.61%
Jul 261.53%
Jun 261.21%
Jun 261.27%
Jun 261.24%
Jun 261.17%
May 261.17%
May 261.18%
May 261.22%
May 261.19%
Apr 261.14%
Apr 261.15%
Apr 261.14%
Apr 261.09%
Apr 261.1%
Mar 260.53%
Mar 260.54%
Mar 260.54%
Mar 260.52%
Feb 260.51%
Feb 260.5%
Feb 260.54%
Feb 260.51%
Jan 260.5%
Jan 260.47%
Jan 260.47%
Jan 260.42%
Jan 260.42%
Dec 25-0.1%
Dec 25-0.1%
Dec 25-0.1%
Dec 25-0.09%
Nov 25-0.09%
Nov 25-0.09%
Nov 25-0.09%
Nov 25-0.09%
Oct 25-0.09%
Oct 25-0.09%
Oct 25-0.08%
Oct 25-0.09%
Oct 25-0.09%
Sep 25-0.13%
Sep 25-0.13%
Sep 25-0.12%
Sep 25-0.13%
Aug 25-0.13%
Aug 25-0.13%
Aug 25-0.13%
Aug 25-0.13%
Aug 25-0.15%
Jul 25-0.18%
Jul 25-0.18%
Jul 25-0.18%
Jul 25-0.18%
Jun 25-0.1%
Jun 25-0.11%
Jun 25-0.11%
Jun 25-0.11%
May 25-0.11%
May 25-0.11%
May 25-0.12%
May 25-0.13%
May 25-0.13%
Apr 25-0.13%
Apr 25-0.14%
Apr 25-0.14%
Apr 25-0.14%
Mar 250.05%
Mar 250.04%
Mar 250.05%
Mar 250.05%
Feb 250.05%
Feb 250.05%
Feb 250.05%
Feb 250.05%
Jan 250.05%
Jan 250.05%
Jan 250.05%
Jan 250.05%
Jan 250.05%
Dec 241.05%
Dec 241.03%
Dec 241.03%
Dec 240.99%
Nov 240.99%
Nov 241.03%
Nov 241.06%
Nov 240.91%
Nov 240.92%
Oct 240.88%
Price to Sales
51015202530med 14.73Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
DUL.DE Price to Sales by quarter
PeriodPrice to Sales
Sep 267.43
Sep 267.73
Sep 268.25
Aug 267.35
Aug 267.32
Aug 267.08
Aug 266.8
Jul 266.37
Jul 268.43
Jul 268.33
Jul 269.29
Jul 269.82
Jun 2610.4
Jun 269.86
Jun 2610.09
Jun 2610.77
May 2610.71
May 2610.6
May 2610.25
May 2610.55
Apr 2611
Apr 2610.88
Apr 2611.02
Apr 2611.5
Apr 2611.38
Mar 2612.97
Mar 2612.83
Mar 2612.9
Mar 2613.18
Feb 2613.67
Feb 2613.84
Feb 2612.86
Feb 2613.47
Jan 2613.91
Jan 2614.75
Jan 2614.69
Jan 2616.33
Jan 2616.34
Dec 2521.15
Dec 2521.35
Dec 2521.06
Dec 2524.41
Nov 2524.1
Nov 2523.15
Nov 2523.93
Nov 2523.46
Oct 2524.33
Oct 2524.55
Oct 2525.35
Oct 2524.44
Oct 2524.35
Sep 2524.72
Sep 2525.02
Sep 2525.82
Sep 2525.05
Aug 2524.7
Aug 2525.19
Aug 2524.75
Aug 2524.15
Aug 2522.08
Jul 2518.17
Jul 2517.63
Jul 2517.36
Jul 2518.2
Jun 2518.44
Jun 2517.81
Jun 2517.66
Jun 2517.32
May 2517.48
May 2516.6
May 2516.38
May 2514.44
May 2514.93
Apr 2514.41
Apr 2513.41
Apr 2513.72
Apr 2513.62
Mar 2516.43
Mar 2517.28
Mar 2514.8
Mar 2515.03
Feb 2515.08
Feb 2515.29
Feb 2515.59
Feb 2516.91
Jan 2516.75
Jan 2517.03
Jan 2515.08
Jan 2514.49
Jan 2514.3
Dec 2412.9
Dec 2413.27
Dec 2413.27
Dec 2413.75
Nov 2413.72
Nov 2413.23
Nov 2412.83
Nov 2414.97
Nov 2414.71
Oct 2415.44
EV/EBITDA
0100200300400med 265.65Oct 24Dec 24Feb 26Apr 26May 26Jul 26Sep 26
DUL.DE EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2632.53
Sep 2633.95
Sep 2636.36
Aug 2632.17
Aug 2632.05
Aug 2630.93
Aug 2629.61
Jul 2627.64
Jul 2637.18
Jul 2636.7
Jul 2641.15
Jul 2643.63
Jun 2661.57
Jun 2658.41
Jun 2659.74
Jun 2663.75
May 2663.39
May 2662.77
May 2660.72
May 2662.44
Apr 2665.12
Apr 2664.4
Apr 2665.25
Apr 2668.07
Apr 2667.33
Mar 26268.44
Mar 26265.65
Mar 26266.93
Mar 26272.87
Feb 26282.94
Feb 26286.39
Feb 26266.17
Feb 26278.88
Jan 26287.85
Jan 26305.3
Jan 26304.12
Jan 26337.95
Jan 26338.11
Dec 24287.75
Dec 24295.92
Dec 24295.88
Dec 24306.56
Nov 24305.99
Nov 24295.05
Nov 24286.17
Nov 24333.77
Nov 24328.08
Oct 24344.26
Oct 24358.27
Oct 24343.17
Oct 24321.11
Price/Operating Cashflow
050001000015000med 167.51Mar 24Jul 24Oct 24Feb 25Feb 26Jun 26Sep 26
DUL.DE Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2644.59
Sep 2646.43
Sep 2649.56
Aug 2644.13
Aug 2643.97
Aug 2642.51
Aug 2640.81
Jul 2638.25
Jul 2650.61
Jul 2649.99
Jul 2655.76
Jul 2658.98
Jun 2673.56
Jun 2669.76
Jun 2671.35
Jun 2676.19
May 2675.75
May 2675.01
May 2672.54
May 2674.61
Apr 2677.84
Apr 2676.97
Apr 2678
Apr 2681.38
Apr 2680.49
Mar 26156.29
Mar 26154.66
Mar 26155.41
Mar 26158.87
Feb 26164.74
Feb 26166.75
Feb 26154.96
Feb 26162.37
Jan 26167.6
Jan 26177.77
Jan 26177.08
Jan 26196.8
Jan 26196.9
Mar 25608.75
Mar 25639.88
Mar 25548.17
Mar 25556.75
Feb 25558.42
Feb 25566.18
Feb 25577.3
Feb 25626.39
Jan 25620.45
Jan 25630.91
Jan 25558.56
Jan 25536.56
Jan 25529.83
Dec 2481.24
Dec 2483.56
Dec 2483.55
Dec 2486.57
Nov 2486.41
Nov 2483.31
Nov 2480.79
Nov 2494.27
Nov 2492.66
Oct 2497.24
Oct 24101.21
Oct 2496.93
Oct 2490.69
Sep 24183.13
Sep 24183.63
Sep 24176.65
Sep 24164.99
Aug 24172.81
Aug 24181.57
Aug 24177.87
Aug 24178.93
Aug 24181.2
Jul 24156.99
Jul 24159.48
Jul 24175.13
Jul 24167.42
Jun 24294.04
Jun 24199.95
Jun 24193.36
Jun 24183.31
May 24180.98
May 24177.82
May 24179.89
May 24181.51
May 24184.36
Apr 24174.58
Apr 24173.86
Apr 24179.97
Apr 24185.9
Mar 249766.09
Mar 249546.1
Mar 249703.89
Mar 249758.46
Mar 249953.67
Feb 2410202.74
Feb 249588.4
Feb 2411095.52
Feb 2411227.82
Jan 2411718.43
Price to Book
050010001500med 224.17Dec 22Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
DUL.DE Price to Book by quarter
PeriodPrice to Book
Sep 2629.56
Sep 2630.78
Sep 2632.85
Aug 2629.25
Aug 2629.15
Aug 2628.18
Aug 2627.05
Jul 2625.36
Jul 2633.55
Jul 2633.14
Jul 2636.97
Jul 2639.1
Jun 2648.85
Jun 2646.33
Jun 2647.38
Jun 2650.59
May 2650.3
May 2649.81
May 2648.17
May 2649.54
Apr 2651.69
Apr 2651.11
Apr 2651.79
Apr 2654.04
Apr 2653.45
Mar 26177.98
Mar 26176.13
Mar 26176.98
Mar 26180.92
Feb 26187.6
Feb 26189.89
Feb 26176.47
Feb 26184.91
Jan 26190.86
Jan 26202.45
Jan 26201.66
Jan 26224.12
Jan 26224.23
Dec 25208.57
Dec 25210.61
Dec 25207.67
Dec 25240.78
Nov 25237.73
Nov 25228.28
Nov 25236.04
Nov 25231.41
Oct 25240.02
Oct 25242.12
Oct 25250.05
Oct 25241.09
Oct 25240.14
Sep 25502.73
Sep 25508.78
Sep 25524.99
Sep 25509.35
Aug 25502.15
Aug 25512.29
Aug 25503.23
Aug 25490.98
Aug 25449.01
Jul 25369.41
Jul 25358.44
Jul 25353.08
Jul 25370.17
Jun 25617.92
Jun 25596.94
Jun 25591.94
Jun 25580.33
May 25585.74
May 25556.26
May 25549.05
May 25483.9
May 25500.23
Apr 25482.95
Apr 25449.35
Apr 25459.65
Apr 25456.4
Mar 251064.09
Mar 251118.52
Mar 25958.21
Mar 25973.21
Feb 25976.12
Feb 25989.68
Feb 251009.12
Feb 251094.93
Jan 251084.55
Jan 251102.83
Jan 25976.37
Jan 25937.91
Jan 25926.14
Dec 22162.76
Dec 22162.89
Dec 22160.71
Dec 22160.27
Nov 22146.02
Nov 22149.06
Nov 22147.58
Nov 22142.14
Oct 22140.35
Oct 22136.31
Alnylam Pharmaceuticals, Inc.
DUL.DE
Stockpicker

Video analysis: DUL.DE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.